Positive results from trial of SNG001 in COVID-19 patients
Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients Patients who received SNG001 had a 79% lower…
Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients Patients who received SNG001 had a 79% lower…
Ambitious annual target on HIV treatment could be achieved for equivalent of just one month of global spend on HIV…
Men in England & Wales miss out on abiraterone as first-line treatment for advanced prostate cancer: The Institute of Cancer…
Urgent action needed on BAME workforce risk assessments: According to a new survey from the Royal Pharmaceutical Society (RPS) and…
Cancers are often heavily reliant on breaking down fats for their growth and spread, and could be treated by a…
A new peer-reviewed study using medicinal cannabidiol in children and adolecents with intellectual disabilities has found that it may reduce…
https://youtu.be/aNDrX-R-WKc A safe and effective vaccine against COVID-19 is generally regarded as the only way out of the COVID-19 crisis,…
Innovative multiple-organ devices for brain diseases - researcher Carmen Giordano has received two further grants totaling €280,000 for her work…
Antiepileptic drugs are associated with a higher risk of mortality in persons with Alzheimer's disease. The use of antiepileptic drugs…
Currently there are no proven treatments for coronavirus. However, there is a huge amount of research going into finding a…
This website uses cookies.